Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (21)

2023

  1. LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors

    Frontiers in Immunology, Vol. 14

  2. Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)

    Bone Marrow Transplantation

2022

  1. A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy

    Cancers, Vol. 14, Núm. 1

  2. Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1

    Oncogene, Vol. 41, Núm. 18, pp. 2638-2650

2021

  1. An Experimental DUAL Model of Advanced Liver Damage

    Hepatology Communications, Vol. 5, Núm. 6, pp. 1051-1068

2020

  1. Autophagic receptor p62 protects against glycation-derived toxicity and enhances viability

    Aging Cell, Vol. 19, Núm. 11

  2. LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity

    Cancer Letters, Vol. 474, pp. 1-14

  3. Spanish Cell Therapy Network (TerCel): 15 years of successful collaborative translational research

    Cytotherapy, Vol. 22, Núm. 1, pp. 1-5

2018

  1. A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms

    Blood Advances, Vol. 2, Núm. 14, pp. 1719-1737

  2. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma

    International Journal of Cancer, Vol. 143, Núm. 5, pp. 1188-1201

  3. PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation

    Annals of Hematology, Vol. 97, Núm. 11, pp. 2217-2224

2017

  1. CCAAT/Enhancer binding protein β silencing mitigates glial activation and neurodegeneration in a rat model of Parkinson's disease

    Scientific Reports, Vol. 7, Núm. 1

  2. DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1

    Cancer Letters, Vol. 386, pp. 196-207

  3. Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches

    Biology of Blood and Marrow Transplantation, Vol. 23, Núm. 12, pp. 2042-2047

2016

  1. Complement component 3 (C3) expression in the hippocampus after excitotoxic injury: Role of C/EBPβ

    Journal of Neuroinflammation, Vol. 13, Núm. 1

2015

  1. CCAAT/Enhancer binding protein β induces motility and invasion of glioblastoma cells through transcriptional regulation of the calcium binding protein S100A4

    Oncotarget, Vol. 6, Núm. 6, pp. 4369-4384

  2. The genotype of the donor for the (GT)n polymorphism in the promoter/enhancer of FOXP3 Is associated with the development of severe acute GVHD but does not affect the GVL effect after myeloablative HLA-Identical allogeneic stem cell transplantation

    PLoS ONE, Vol. 10, Núm. 10

2014

  1. Functional characterization of thioredoxin 3 (TRX-3), a Caenorhabditis elegans intestine-specific thioredoxin

    Free Radical Biology and Medicine, Vol. 68, pp. 205-219

2013

  1. A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT

    Bone Marrow Transplantation, Vol. 48, Núm. 9, pp. 1205-1211

2012

  1. The TT genotype of the STAT4 rs7574865 polymorphism is associated with high disease activity and disability in patients with early arthritis

    PLoS ONE, Vol. 7, Núm. 8